Immune Therapeutics Inc (PK) (IMUN)
USOTC
The current IMUN market cap is 7.78M. The company's latest EPS is USD -0.0197 and P/E is -3.05.
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -2.84M | -887k | -739k | -1.16M | -1.49M |
Net Income | -3.4M | 1.59M | 3.59M | -3.54M | -1.65M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 6k | 10k | 3.14M | 964k | 743k |
Total Liabilities | 13.69M | 11.68M | 11.09M | 3.48M | 4.56M |
Total Equity | -13.69M | -11.67M | -7.95M | -2.51M | -3.82M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -1,000 | -192k | -232k | -582k | -657k |
Investing | N/A | N/A | N/A | -500k | N/A |
Financing | N/A | 197k | 716k | 738k | 536k |
Market Cap | 7.78M |
Price to Earnings Ratio | -3.05 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 150 |
Price to Book Ratio | -1.32 |
Dividend Yield | - |
Shares Outstanding | 83.66M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | -28.46% |
52 Week High | 0.13 |
52 Week Low | 0.06675 |
Spread (Intraday) | 0.03 (28%) |
Company Name | Immune Therapeutics Inc (PK) |
Address |
37 north orange ave, suite 607 orlando, florida 32801 |
Website | https://www.immunetherapeutics.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.